ArticleThe Kaohsiung journal of medical sciences2024

In vitro and in vivo effects of Galectin-3 inhibitor TD139 on inflammation and ERK/JNK/p38 pathway in gestational diabetes mellitus.

Ji Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.